Cleared Traditional

K240854 - Accelerate Arc System (FDA 510(k) Clearance)

Sep 2024
Decision
182d
Days
Class 2
Risk

K240854 is an FDA 510(k) clearance for the Accelerate Arc System. This device is classified as a Mass Spectrometry, Microorganism Identification, Blood Culture (Class II - Special Controls, product code QNJ).

Submitted by Accelerate Diagnostics, Inc. (Tucson, US). The FDA issued a Cleared decision on September 26, 2024, 182 days after receiving the submission on March 28, 2024.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3378. Blood Culture Processing Device That Includes Associated Reagents That Are Intended To Concentrate And Purify Microbial Cells From Blood Culture Samples Identified As Positive By A Continuous Monitoring Blood Culture System With Organisms Subsequently Identified By Spectrometry..

Submission Details

510(k) Number K240854 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 28, 2024
Decision Date September 26, 2024
Days to Decision 182 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code QNJ - Mass Spectrometry, Microorganism Identification, Blood Culture
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.3378
Definition Blood Culture Processing Device That Includes Associated Reagents That Are Intended To Concentrate And Purify Microbial Cells From Blood Culture Samples Identified As Positive By A Continuous Monitoring Blood Culture System With Organisms Subsequently Identified By Spectrometry.